Literature DB >> 22875458

Lack of predictive value of FGF23 levels on pulse wave velocity.

L Desjardins, S Liabeuf, Z A Massy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22875458     DOI： 10.1007/s00198-012-2037-3

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  6 in total

1.  FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart.

Authors:  Martin L Ford; Edward R Smith; Laurie A Tomlinson; Prabal K Chatterjee; Chakravarthi Rajkumar; Stephen G Holt
Journal:  Nephrol Dial Transplant       Date:  2011-07-12       Impact factor: 5.992

2.  FGF23: instability may affect accuracy and interpretation.

Authors:  E R Smith; L P McMahon; S G Holt
Journal:  Osteoporos Int       Date:  2012-08-09       Impact factor: 4.507

3.  Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.

Authors:  Tamara Isakova; Huiliang Xie; Wei Yang; Dawei Xie; Amanda Hyre Anderson; Julia Scialla; Patricia Wahl; Orlando M Gutiérrez; Susan Steigerwalt; Jiang He; Stanley Schwartz; Joan Lo; Akinlolu Ojo; James Sondheimer; Chi-yuan Hsu; James Lash; Mary Leonard; John W Kusek; Harold I Feldman; Myles Wolf
Journal:  JAMA       Date:  2011-06-15       Impact factor: 56.272

4.  FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.

Authors:  L Desjardins; S Liabeuf; C Renard; A Lenglet; H-D Lemke; G Choukroun; T B Drueke; Z A Massy
Journal:  Osteoporos Int       Date:  2011-11-23       Impact factor: 4.507

5.  Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies.

Authors:  Edward R Smith; Martin L Ford; Laurie A Tomlinson; Gary Weaving; Bernard F Rocks; Chakravarthi Rajkumar; Stephen G Holt
Journal:  Clin Chim Acta       Date:  2011-02-12       Impact factor: 3.786

6.  Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

Authors:  Orlando M Gutiérrez; Michael Mannstadt; Tamara Isakova; Jose Alejandro Rauh-Hain; Hector Tamez; Anand Shah; Kelsey Smith; Hang Lee; Ravi Thadhani; Harald Jüppner; Myles Wolf
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.